TRCT
SGYPW

Tower Research Capital (TRC)’s Synergy Pharmaceuticals, Inc. - Warrants SGYPW Stock Holding History

Tower Research Capital (TRC)’s Portfolio SGYPW Stock Details SGYPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-80
Closed – – 5149
2016
Q2 		$0 Sell
80
-800
-91% -$511 ﹤0.01% 5420
2016
Q1 		$1K Sell
880
-300
-25% -$288 ﹤0.01% 3956
2015
Q4 		$2K Sell
1,180
-314
-21% -$623 ﹤0.01% 3933
2015
Q3 		$2K Buy
1,494
+131
+10% +$461 ﹤0.01% 3509
2015
Q2 		$5K Buy
1,363
+1,309
+2,424% +$2.3K ﹤0.01% 3321
2015
Q1 		$0 Sell
54
-159
-75% -$130 ﹤0.01% 5312
2014
Q4 		$0 Sell
213
-516
-71% -$351 ﹤0.01% 5212
2014
Q3 		$1K Buy
729
+20
+3% +$24 ﹤0.01% 4262
2014
Q2 		$1K Sell
709
-331
-32% -$540 ﹤0.01% 3864
2014
Q1 		$2K Buy
1,040
+960
+1,200% +$2.1K ﹤0.01% 3992
2013
Q4 		$0 Buy
80
+40
+100% +$66 ﹤0.01% 5231
2013
Q3 		$0 Sell
40
-600
-94% -$1.14K ﹤0.01% 5078
2013
Q2 		$1K Buy
+640
New +$1.5K ﹤0.01% 3817

Other funds holding SGYPW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Tower Research Capital (TRC)'s SGYPW Position: Q3 2016 in Review

Tower Research Capital (TRC) sold out of Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) in Q3 2016, closing a stake of 80 shares.

Tower Research Capital (TRC) first reported a position in SGYPW in Q2 2013 and held it in 13 quarters. The position peaked at $5K in Q2 2015. 3 funds tracked by Wall St. Rank hold SGYPW as of Q3 2016.

  • Tower Research Capital (TRC) reported no remaining Synergy Pharmaceuticals, Inc. - Warrants position as of Q3 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 80 Synergy Pharmaceuticals, Inc. - Warrants shares in Q3 2016.
  • Tower Research Capital (TRC) first reported a position in Synergy Pharmaceuticals, Inc. - Warrants in Q2 2013 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Synergy Pharmaceuticals, Inc. - Warrants position peaked at $5K in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc. - Warrants as of Q3 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.